Technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases are the major factors driving the growth of the market.
[175 Pages Report] Single-cell Analysis Market is estimated to grow at a CAGR of 16.5% during the forecast period, to reach $ 3.59 billion
The Single-cell Analysis Market, by cell type, is segmented into human, animal, and microbial cells. the human cells segment is expected to account for the largest share of the market. The growing application areas of human stem cells and the rising incidence of diseases such as cancer are the major factors driving the growth of this segment.
Speak to our analyst and gain crucial industry insights that will help your business grow:
The objectives of this study are as follows:
Browse and in-depth TOC on “Single-cell Analysis Market”.
107 — Tables
42 — Figures
175 — Pages
Single-cell Analysis Market, By Technique
Request for Free Sample Report @
Single-cell Analysis Market, By Region:
The Single-cell Analysis Market is highly fragmented in nature with several big as well as emerging players. Prominent players in this market include Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), and Agilent Technologies (U.S.).
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly